Standard BioTools Inc. Inventory Valuation Reserves
Standard BioTools Inc. (LAB) had Inventory Valuation Reserves of $700.00 thousand as of 2024-03-31, per its 10-Q filed 2024-05-09.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:InventoryValuationReserves · last filed 2024-05-09
- 2024-03-31: Inventory Valuation Reserves $700.00K.
- 2023-12-31: Inventory Valuation Reserves $7.04M.
- 2023-09-30: Inventory Valuation Reserves $6.76M.
- 2023-06-30: Inventory Valuation Reserves $7.67M.
| Period end | Inventory Valuation Reserves | Inventory Valuation Reserves as first filed |
|---|---|---|
| 2024-03-31 | $700.00K 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $7.04M 10-K · filed 2024-03-01 | |
| 2023-09-30 | $6.76M 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $7.67M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $400.00K 10-Q · filed 2024-05-09 | $7.76M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $11.58M 10-K · filed 2024-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |